• ثبت نام
    • ورود به سامانه
    مشاهده مورد 
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Asian Pacific Journal of Cancer Prevention
    • Volume 9, Issue 1
    • مشاهده مورد
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Asian Pacific Journal of Cancer Prevention
    • Volume 9, Issue 1
    • مشاهده مورد
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Alcohol Dehydrogenase-2 and Aldehyde Dehydrogenase-2 Genotypes, Alcohol Drinking and the Risk of Primary Hepatocellular Carcinoma in a Chinese Population

    (ندگان)پدیدآور
    پدیدآور نامشخص
    Thumbnail
    دریافت مدرک مشاهده
    FullText
    اندازه فایل: 
    35.84کیلوبایت
    نوع فايل (MIME): 
    PDF
    نوع مدرک
    Text
    زبان مدرک
    English
    نمایش کامل رکورد
    چکیده
    Objective: To investigate the relationship of alcohol dehydrogenase-2 (ADH2) and aldehyde dehydrogenase-2 (ALDH2) genotypes as well as alcohol drinking to the susceptibility of primary hepatocellular carcinoma(HCC). Methods: A case-control study including 208 cases of HCC and 208 controls matched with sex, age andresidential area was carried out in Taixing city of Jiangsu province, China. Blood samples were collected andtested for ADH2 and ALDH2 genotypes by PCR-RFLP method. Results: There were no significant differencesin the frequency of either ADH2 or ALDH2 genotypes between cases and controls. Compared with no-drinkerspossessing ALDH21*1 genotypes, drinkers with ALDH21*2 or ALDH22*2 genotypes and cumulative amountof alcohol consumption >3 (Kg * years) were at a significantly higher risk of developing HCC (OR=3.30, 95%CI:1.24-8.83). In contrast, there was no significant difference in cancer risk between no-drinkers with ADH21*1and drinkers with ADH2 1*2 or ADH22*2 genotypes. A dose-dependent positive result was found (P=0.044)between cumulative amount of alcohol consumption and the risk of HCC in individuals carrying ALDH21*2 orALDH22*2 genotypes. Drinkers with cumulative amount of alcohol consumption >3 (Kg * years) who possessedboth inactive ALDH2 (ALDH21*2 or ALDH22*2) and inactive ADH (ADH21*2 or ADH22*2) genotypes werenot at a significantly higher risk of HCC (adjusted OR=4.26, 95%CI: 0.63-29.08) compared to no-drinkerspossessing ADH21*1 and ALDH21*1 genotypes. Compared with individuals possessing ALDH21*1, with negativeHBsAg and cumulative amount of alcohol consumption ≤3 (Kg * years), those with ALDH21*2 or ALDH22*2,positive HBsAg, and cumulative amount of alcohol consumption >3 (Kg * years) had a significantly higher riskof HCC (OR=49.71, 95%CI: 5.51–448.96). 3 (Kg * years) were at a significantly higher risk of developing HCC (OR=3.30, 95%CI:1.24-8.83). In contrast, there was no significant difference in cancer risk between no-drinkers with ADH21*1and drinkers with ADH2 1*2 or ADH22*2 genotypes. A dose-dependent positive result was found (P=0.044)between cumulative amount of alcohol consumption and the risk of HCC in individuals carrying ALDH21*2 orALDH22*2 genotypes. Drinkers with cumulative amount of alcohol consumption >3 (Kg * years) who possessedboth inactive ALDH2 (ALDH21*2 or ALDH22*2) and inactive ADH (ADH21*2 or ADH22*2) genotypes werenot at a significantly higher risk of HCC (adjusted OR=4.26, 95%CI: 0.63-29.08) compared to no-drinkerspossessing ADH21*1 and ALDH21*1 genotypes. Compared with individuals possessing ALDH21*1, with negativeHBsAg and cumulative amount of alcohol consumption ≤3 (Kg * years), those with ALDH21*2 or ALDH22*2,positive HBsAg, and cumulative amount of alcohol consumption >3 (Kg * years) had a significantly higher riskof HCC (OR=49.71, 95%CI: 5.51–448.96). 3 (Kg * years) who possessedboth inactive ALDH2 (ALDH21*2 or ALDH22*2) and inactive ADH (ADH21*2 or ADH22*2) genotypes werenot at a significantly higher risk of HCC (adjusted OR=4.26, 95%CI: 0.63-29.08) compared to no-drinkerspossessing ADH21*1 and ALDH21*1 genotypes. Compared with individuals possessing ALDH21*1, with negativeHBsAg and cumulative amount of alcohol consumption ≤3 (Kg * years), those with ALDH21*2 or ALDH22*2,positive HBsAg, and cumulative amount of alcohol consumption >3 (Kg * years) had a significantly higher riskof HCC (OR=49.71, 95%CI: 5.51–448.96). 3 (Kg * years) had a significantly higher riskof HCC (OR=49.71, 95%CI: 5.51–448.96). Conclusion: These results revealed that it was not ADH2 but ALDH2polymorphisms that had a significant interaction with heavy alcohol consumption in the development of HCC.This result suggests that to help lower their risk for HCC , persons with ALDH21*2 or ALDH22*2 genotypesshould be encouraged to reduce their consumption of alcoholic beverages.
    کلید واژگان
    alcohol
    Consumption
    Metabolism
    HCC
    China

    شماره نشریه
    1
    تاریخ نشر
    2008-01-01
    1386-10-11
    ناشر
    West Asia Organization for Cancer Prevention (WAOCP)

    شاپا
    1513-7368
    2476-762X
    URI
    http://journal.waocp.org/article_24689.html
    https://iranjournals.nlai.ir/handle/123456789/29616

    مرور

    همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

    حساب من

    ورود به سامانهثبت نام

    آمار

    مشاهده آمار استفاده

    تازه ترین ها

    تازه ترین مدارک
    © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
    تماس با ما | ارسال بازخورد
    قدرت یافته توسطسیناوب